• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcmicrBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Microbiology
BMC Microbiol. 2008; 8: 226.
Published online Dec 17, 2008. doi:  10.1186/1471-2180-8-226
PMCID: PMC2644699

Functional identification of HugZ, a heme oxygenase from Helicobacter pylori

Abstract

Background

Iron is recognized as an important trace element, essential for most organisms including pathogenic bacteria. HugZ, a protein related to heme iron utilization, is involved in bacterial acquisition of iron from the host. We previously observed that a hugZ homologue is correlated with the adaptive colonization of Helicobacter pylori (H. pylori), a major gastro-enteric pathogen. However, its exact physiological role remains unclear.

Results

A gene homologous to hugZ, designated hp0318, identified in H. pylori ATCC 26695, exhibits 66% similarity to cj1613c of Campylobacter jejuni NCTC 11168. Soluble 6 × His fused-HugZ protein was expressed in vitro. Hemin-agrose affinity analysis indicated that the recombinant HugZ protein can bind to hemin. Absorption spectroscopy at 411 nm further revealed a heme:HugZ binding ratio of 1:1. Enzymatic assays showed that purified recombinant HugZ protein can degrade hemin into biliverdin and carbon monoxide in the presence of either ascorbic acid or NADPH and cytochrome P450 reductase. The biochemical and enzymatic characteristics agreed closely with those of Campylobacter jejuni Cj1613c protein, implying that hp0318 is a functional member of the HugZ family. A hugZ deletion mutant was obtained by homologous recombination. This mutant strain showed poor growth when hemoglobin was provided as the source of iron, partly because of its failure to utilize hemoglobin efficiently. Real-time quantitative PCR also confirmed that the expression of hugZ was regulated by iron levels.

Conclusion

These findings provide biochemical and genetic evidence that hugZ (hp0318) encodes a heme oxygenase involved in iron release/uptake in H. pylori.

Background

Helicobacter pylori (H. pylori), a Gram-negative microaerophilic spiral bacterium, is known as the major pathogenic agent in a wide range of gastroenteric diseases exemplified by chronic gastritis, peptic ulcer and gastric adeno-carcinoma [1,2]. Increasing evidence suggests that H. pylori has adapted particularly to the niche of human stomach. Genetic diversity is widespread among the clinical isolates [3]. This polymorphism can be attributed mainly to the consequence of adaptive changes during colonization, which in turn imply that H. pylori has a specialized adaptation mechanism [4-6].

In our earlier study, we harvested several clinical strains of H. pylori, which initially grew weakly in Mongolian gerbils but subsequently adapted after 13 serial passages in vivo [6]. To elucidate the adaptive colonizing mechanisms of H. pylori in Mongolian gerbils further, we applied proteomic approaches to one representative H. pylori isolate. Fortunately, four adaptive colonization-associated proteins were identified, among which HugZ (heme iron utilization-related protein) was implicated in adaptive colonization by H. pylori for the first time [6]. However, the exact physiological role of HugZ remains elusive.

Iron is regarded as an essential trace element in living organisms, including pathogenic bacteria. It has been suggested that acquisition of iron by H. pylori from the host environment is required for colonization, infection and resulting disease [7-9]. Nevertheless, intracellular bacterial iron is precisely regulated and maintained at an appropriate level. Most of the free iron ion in the host is complexed with high-affinity binding proteins such as transferrin in the serum and lactoferrin on mucosal surfaces, so the level of extracellular iron available in the host is extremely low. Consequently, bacterial pathogens including H. pylori must have developed some mechanism to compete for the limited host iron for their survival and infection cycle [10-12].

As we know, the siderophore is a common iron acquisition apparatus/system in many pathogens; it obtains iron from transferrin or lactoferrin in the host [10,11]. Other bacteria are also capable of utilizing heme complexes as iron sources. Acquisition can be described as comprising the following steps: binding, uptake and degradation of heme [12]. Some pathogens (such as Campylobacter jejuni (C. jejuni), Vibrio cholerae and Yersinia entercolitica) have developed iron-dependent outer membrane receptors specific for heme [13-15]. Heme is transported through such receptors via a TonB-mediated gated pore mechanism [12,15,16], then a periplasmic heme binding protein transports it to the cytoplasmic membrane, where a classical permease/ATPase is thought to transport it actively into the cytoplasm. Once the heme is located within the cytoplasm, a heme oxygenase protein (e.g. hemO) can utilize it. Heme oxygenase is rate-limiting in the degradation process, catalyzing the NADPH-reductase-dependent cleavage of heme to biliverdin with the release of iron and carbon monoxide [17,18]. In H. pylori, the mechanism of utilization of heme iron is not yet completely clear. Although several heme iron-repressible outer membrane proteins (IROMPs) might be involved in heme binding and/or uptake [19,20] by H. pylori, we still do not know which component functions as the heme oxygenase. In this report, we present the functional identification of HugZ as a heme oxygenase activity in H. pylori. Our data imply that the release of iron from heme by HugZ may play a crucial role in the pathogenicity of H. pylori.

Results

Production and evaluation of homogeneous H. pylori HugZ

Bioinformatics analysis suggested that a hugZ homologue exists in H. pylori, which is very similar to that in C. jejuni (Fig. (Fig.1).1). To test its activity in iron acquisition, we prepared homogeneous H. pylori HugZ protein in vitro. Initially, soluble 6 × His-tagged HugZ protein was expressed in a prokaryotic expression system; expression in Escherichia coli (E. coli) turned the LB medium green (data not shown), implying the presence of a reductase. This observation supports the hypothesis that catalytic turnover of Heme-HugZ triggers the accumulation of biliverdin, which is consistent with the expression profiles of prokaryotic/eukaryotic heme oxygenases [21,22]. The recombinant HugZ protein purified by a Chelating Fastflow XK1610 column (CV = 18 ml) yielded 50 mg/liter and showed about 95% purity on 15% SDS-PAGE (Fig. (Fig.2A),2A), indicating high homogeneity. PMF-based sequencing showed that H. pylori HugZ is 251 amino acids long and shares 100% similarity to HP0318 (HugZ) protein in ATCC 26695.

Figure 1
Amino acid sequence alignment of the C. jejuni heme oxygenase (Cj1613c) with H. pylori HugZ. The alignment was performed using the WebESPript 2.2 program on the Institut de Biologie et Chimie des Protéines website.
Figure 2
SDS-PAGE of the purified recombinant HugZ protein and binding of HugZ to hemin-agarose. (A) lane 1, molecular mass markers; lane 2, pET22b-hugZ/E. coli BL21(DE3); lane 3, purified 6 × His-HugZ; (B): lane 1, molecular mass markers;lane 2, purified ...

To determine whether it is a functional member of the heme oxygenase family, two kinds of heme binding assay were performed. HugZ binding to hemin-agarose beads strongly indicated that it has heme-binding activity (Fig. (Fig.2B).2B). Similarly, in vitro absorption spectroscopy suggested that HugZ is able to bind heme. As we expected, when HugZ was mixed with hemin, the spectrum of the complex showed a typical spectrographic curve with a prominent Soret peak at 411 nm, and a shoulder at 540 nm and a smaller peak at 580 nm, corresponding to the β- and α-porphyrin bands of the heme-HugZ complex respectively (Fig. (Fig.3A).3A). To quantify heme binding, HugZ solution (20 μM) was titrated with increasing amounts of hemin (Fig. (Fig.3).3). The increase in absorption leveled off at approximately 20 μM heme, showing a 1:1 stoichiometry of heme to HugZ (Fig. (Fig.3B3B).

Figure 3
Absorption spectroscopy of hemin binding to recombinant HugZ. (A) Absoption profile of hemin at various concentrations. Hemin (2.5 mM in 20 mM NaOH) was titrated in 2.5 μM increments (0, 2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25, 27.5, 30 ...

HugZ catalyzes the degradation of heme

It has been suggested that some heme binding proteins can degrade heme by so-called coupled oxidation, a non-enzymatic mechanism [14]. Coupled oxidation involves the generation of peroxide by the heme protein and is prevented if catalase is present. Heme oxygenases catalyze the opening of the heme macro-cycle in the presence of an electron donor. Purified heme oxygenase has been shown not to release the product biliverdin readily in the absence of biliverdin reductase [21]. Thus, most studies involve single turnover assays, as was done here. In addition, the in vivo electron donor for bacterial heme oxygenases is not known, but ascorbate or NADPH-cytochrome P450 reductase may be used for catalysis by the pure enzyme [21,23]. In the first experiment, heme degradation catalyzed by HugZ was measured spectrophotometrically using human NADPH-CPR as the electron donor (Fig. (Fig.4A).4A). NADPH was added to the reaction mixture in 10 μM increments and the mixture was scanned from 350 to 800 nm after each addition. The Soret band decreased successively after addition of NADPH. Finally, the HugZ substrate-hemin was exhausted and the NADPH was not oxidized completely, so there was absorption at 340 nm due to NADPH. Heme degradation did not occur if HugZ, NADPH or CPR was omitted from the reaction mixture (not shown).

Figure 4
Degradation of the heme:HugZ complex in the presence of NADPH-cytochrome P450 reductase and ascorbic acid. (A) Degradation of hemin using recombinant human NADPH-cytochrome P450 reductase as the reductant. Arrows indicate the positions and directions ...

In the second experiment, the HugZ-dependent disappearance of heme was measured using 20 mM ascorbate as the reductant (Fig. (Fig.4B).4B). Heme was degraded more rapidly with ascorbate than with human NADPH-CPR, and most of the decrease was complete by 20 min after the ascorbate was added. No degradation of heme was observed in the absence of HugZ or ascorbate (not shown). Collectively, these findings showed that HugZ catalyzes the enzymatic degradation of heme.

Biliverdin and CO produced by HugZ-catalyzed heme degradation

Biliverdin is the final product of heme degradation by heme oxygenases. When heme was degraded by HugZ, a broad absorbance peak in the 660-nm region became prominent, implying is the presence of biliverdin. To determine the kind of biliverdin formed, we subjected this product to HPLC analysis. HPLC chromatography of all four possible biliverdin isomers is shown for comparison (Fig. (Fig.5).5). The HPLC profiles of the products formed during HugZ-catalyzed heme degradation with ascorbate and NADPH gave a retention time and absorption spectrum identical to that of biliverdin IXδ.

Figure 5
HPLC detection of the product of the HugZ reaction with NADPH cytochrome P450 reductase. (A): HPLC chromatogram of a mixture of all four biliverdin isomers as standards. (B): Spectroscopy and HPLC product analysis both show that a product of heme degradation ...

The much higher affinity of myoglobin for CO than for oxygen allows the CO produced by oxidative cleavage of the heme to be detected [21]. Difference absorption spectroscopy in the presence of myoglobin confirmed CO as a product of the oxidative cleavage of heme by HugZ. The myoglobin absorption spectrum was recorded at 2-min intervals in order to monitor the characteristic spectral changes of a myoglobin-CO complex (Fig. (Fig.6).6). The transition of ferrous-dioxygen myoglobin to the ferrous-CO myoglobin complex was associated with a shift in the Soret band from 411 to 421 nm as well as the appearance of bands at 540 and 580 nm. Control reactions in the absence of the heme-HugZ complex showed no shift in the Soret band. The complete conversion indicated that carbon monoxide as well as biliverdin was generated as a product of oxidative heme cleavage in H. pylori.

Figure 6
Difference absorption spectra of the heme-HugZ and NADPH cytochrome P450 reductase reaction in the presence of myoglobin. The reference and sample cuvettes contained the hemin-HugZ complex (20 μM), recombinant human NADPH reductase (100 μg) ...

HugZ is a cytoplasmic protein

To determine the cellular location of HugZ, Immunoelectron microscopy (IEM) was performed. Frozen sectioned samples of H. pylori 26695 strains were treated with anti-HugZ antibodies and gold-labeled secondary antibodies. Analysis of the positions of the gold particles (Fig. (Fig.7B)7B) revealed that HugZ was predominantly located in the cytoplasm in H. pylori cells.

Figure 7
IEM analysis of HugZ location in H. pylori 26695. Representative immuno-electron micrographs of frozen thin-sectioned specimens are shown. Labeling in the H. pylori cytoplasm (B) was strong in comparison to the negative control (A). The cell wall shows ...

The hugZ mutant fails to utilize heme iron for normal growth

In order to elucidate the role of HugZ, the mutant ΔhugZ was obtained from more than 100 H. pylori transformants. The correct genotype of ΔhugZ was systemically confirmed by PCR (Fig. 8A & 8B), RT-PCR (Fig. (Fig.8C)8C) and direct DNA sequencing (data not shown).

Figure 8
Identification of hugZ, the isogenic mutant of hugZ in H. pylori 26695. (A) Cartoon description of hugZ knockout from the H. pylori 26695 chromosome. pBSKΔhugZ::cam is the recombinant vector constructed specifically to inactivate hugZ. hugZLA ...

The hugZ deletion mutant (ΔhugZ) grew normally in liquid BBF and on BBF blood agar plates, indicating that HugZ is not required for bacterial growth under iron-replete conditions. Subsequently, we tested its growth in the presence of different iron sources. ΔhugZ strains showed poor growth in iron-restricted conditions while the wild type grew well (Fig. (Fig.9).9). These data suggest that the hugZ mutant cannot utilize heme iron for normal growth.

Figure 9
Growth of hugZ mutants. Samples were tested in triplicate, and the data plotted are the means of three independent experiments together with the sample error. Symbols: A: H. pylori 26695 WT and ΔhugZ strains grown in BBF supplemented with 50 μM ...

Regulation of hugZ expression by iron

Merrell et al. reported that hugZ (hp0318) was one of the genes induced by iron starvation [24]. To test whether hugZ is regulated by iron, real-time quantitative PCR was performed. The effects of different iron levels on hugZ transcription varied (Fig. (Fig.10).10). Transcription was suppressed by FeCl3 (compared to BBF, the change fold ratio was 0.410 ± 0.056 (p < 0.01, Student's t-test)) and stimulated under iron-restricted conditions (compared to BBF, the change fold ratio was 3.90 ± 0.010 (p < 0.01, Student's t-test)). These results indicated that hugZ (hp0318) is down-regulated by iron.

Figure 10
Comparison of the levels of hugZ expression under different iron level conditions, detected by real-time quantitative RT-PCR. The results are based on the ratio hugZ mRNA amplification/gyrB mRNA amplification, which are presented as the fold induction ...

Discussion

A wide array of metal ions including iron, copper and nickel are known to be closely related to H. pylori colonization and infection [25,26]. Iron metabolism-related proteins play important roles in H. pylori infections. However, the iron-specific metabolic mechanism in H. pylori is still not well understood. Bacteria require iron to complete their life cycles and in particular for growth and infection. The limited availability of extra-cellular iron in the host, which is partly due to iron insolubility, restricts microbial growth greatly, so iron acquisition seems to be crucial for the survival of pathogens. Actually, it has been suggested that bacteria evolve sophisticated systems to compete for iron with their hosts. In general, heme is an important iron source in hosts and it can be utilized by most pathogens. Heme is degraded by heme oxygenase in the bacterial cytoplasm, releasing the iron.

Heme oxygenase is the rate-limiting enzyme in heme degradation; it catalyzes reduction system-dependent cleavage of heme to biliverdin with the release of iron and carbon monoxide. It is reasonable to suppose that bacterial heme oxygenase releases the iron from heme for subsequent use by the invading pathogen [18]. Heme oxygenases are widespread among pathogenic bacteria such as C. jejuni and Y. pestis and play key roles in the growth and colonization of those pathogens [13,27]. Heme oxygenase mutants of Corynebacterium diphtheriae and Neisseria meningitidis were unable to utilize heme or hemoglobin as an iron source [28,29]. Similarly, it has been suggested that heme oxygenase (Cj1613c) is necessary for growth in C. jejuni [13]. For H. pylori, the role of heme degradation in iron metabolism is relatively obscure. In this study, we identified a heme oxygenase called HugZ that is responsible for heme iron utilization in H. pylori. The heme oxygenase activity of HugZ was confirmed by the appearance of characteristic spectral changes following addition of ascorbic acid or a NADPH-CPR system as electron donor. HugZ binds to hemin in vitro at 1:1 and produces absorbance bands at 411, 540 and 580 nm, which are similar to those reported for other heme oxygenases such as ChuS [30] and Cj1613c [13]. The formation of a broad absorbance band at 395 and 660 nm suggests that the end product of heme degradation is iron-free biliverdin rather than ferric biliverdin [28].

We demonstrated that the products of hugZ cleave heme to carbon monoxide and biliverdin IXδ, which shows that the δ-meso carbon bridge position in the heme precursor is eliminated by HugZ. As with various eukaryotic and prokaryotic heme oxygenases, overexpression of HugZ in E. coli can make the culture medium green owing to the accumulation of biliverdin. It is presumed that during the expression of those exogenous heme oxygenases in E. coli, reducing systems in the bacterium support the catalytic turnover of heme [21,22]. Furthermore, several reduction systems including human CPR and ascorbic acid can support biliverdin production by purified recombinant HugZ in vitro. These results suggest that H. pylori probably has the same reduction partners for HugZ-heme oxygenase activity.

Further experiments showed that the H. pylori hugZ mutant exhibited poor growth, though wild type strains grew well when heme was added to iron-restricted BBF, indicating that the hugZ mutant cannot effectively utilize hemoglobin as a heme iron source, which confirmed that HugZ is a heme oxygenase.

In mammals, the primary function of heme oxygenases is to maintain iron homeostasis, whereas prokaryotic heme oxygenases help bacteria to take in iron from heme. Most bacterial heme oxygenases are regulated by the ferric uptake repressor (Fur). Fur requires iron to bind to target DNA sequences (Fur-boxes) and controls the expression of iron-regulated genes [18]. Merrell and Gancz et al. used a Microarray to analyze the expression of iron-regulated genes in H. pylori and reported that hp0318 (hugZ) is one of the genes induced by iron starvation; they presumed that a hypothetical Fur box located before hp0321 controls hp0318 expression [24,31]. Our real-time quantitative RT PCR results also support that the view that hugZ (hp0318) is down-regulated by iron. However, further studies are needed to determine whether the presumed Fur box controls the transcription of hugZ.

Conclusion

Taken together, these findings confirm that H. pylori HP0318 (HugZ) is a heme oxygenase. Our data imply that HugZ may play a crucial role in the acquisition of heme iron by H. pylori.

Methods

Bacterial strains and growth conditions

H. pylori strain ATCC 26695 was cultivated in liquid Brucella Broth with 10% fetal bovine serum (BBF) and a mixture of antibiotics (10 μg/ml vancomycin, 5 μg/ml trimethoprim, 6 μg/ml nalidixic acid and 5 μg/ml amphotericin B). The solid medium consisted of the aforementioned ingredients with 5% rabbit blood and 1.5% agar at 37°C under microaerobic conditions (10% CO2, 85% N2, 5% O2) [32]. Iron-replete conditions were achieved by adding FeCl3 to a final concentration of 50 μM. Iron-restricted conditions were achieved by adding the iron chelator desferrioxamine mesylate (Desferal) to a final concentration of 75 μM [19]. H. pylori strains were grown in the presence of heme as the sole iron source at a final concentration of 12.5 μM hemoglobin in iron-restricted BBF. The strains were initially cultured on BBF blood agar plates overnight, harvested in a suitable volume of BBF, and used to inoculate 5 ml BBF to an optical density at 600 nm (OD600) of 0.05. The cultures were incubated microaerobically with shaking, and the optical density was monitored at regular time intervals.E. coli strains DH5α and BL21 (DE3) were used as cloning host and expression host, respectively. Antibiotic selection was achieved when necessary by addition of ampicillin (100 μg/ml) or chloramphenicol (10 μg/ml).

Construction of hugZ knockout mutant

hugZ was activated by allelic replacement with a constitutively-expressed chloramphenicol resistance (CamR) cassette. First, the DNA sequences flanking hugZ, including 1000 base pairs upstream and 1000 base pairs downstream, were amplified from the chromosomal DNA of H. pylori 26695 using PCR with two pairs of specific primers (LA-F1/LA-R1 and RA-F1/RA-R1) carrying SacI/XbaI and SmaI/SalI restriction enzyme sites, respectively (Table (Table1).1). After digestion with the corresponding restriction enzymes, the DNA fragments were cloned directionally into a pBluescript II SK(-) vector. The CamR gene cassette (from phel2 [33]) was then inserted at the XbaI/SmaI sites to generate the hugZ knockout vector pBSKΔhugZ::camR. To obtain the isogenic mutant ΔhugZ, the plasmid pBSKΔhugZ::camR was electrotransformed into H. pylori 26695, where the CamR marked mutation was introduced into the genome by homologous recombination, resulting in the hugZ::camR mutant strain. PCR was used to examine all the CamR transformants with a series of specific primers.

Table 1
Oligonucleotide primers used in this study

Overexpression and purification of recombinant HugZ and preparation of HugZ antiserum

After the amino acid sequence of HugZ (HP0318 located in Helicobacter pylori 26695) was aligned with that of Cj1613c of C. jejuni NCTC 11168 [13,32], it was recognized as a candidate/functional member related to iron acquisition. To test this bioinformatics-based hypothesis, the full length 753 bp hugZ was amplified with primers H1 (with NdeI site) and H2 (with XhoI site) (Table (Table1),1), using genomic H. pylori ATCC 26695 DNA as template. The PCR conditions were initial denaturation for 10 min (95°C) followed by 35 cycles of amplification (40 s at 95°C, 30 s at 53°C and 1 min at 72°C) and a final extension for 10 min at 72°C, using a gene cycler (BIORAD). The PCR product was cloned into the pMD-18T vector (Takara), generating pMD-18T-hugZ, and directly subcloned into pET-22b (+) (Novagen) via Nde I and Xho I restriction sites, resulting in the recombinant expression plasmid pET-22b-hugZ. Finally, the positive clones were further confirmed by direct DNA sequencing. For the expression of HugZ protein, an overnight culture of strain BL21 (pET22b-hugZ) was diluted 1:100 into 2000 ml of LB medium; 0.5 mM IPTG (isopropyl β-D-thio β-D-galacto-pyranoside; Sigma) was added when the OD600 reached 0.6 and the culture was maintained for 12 h at 16°C with shaking. Cells were harvested by centrifugation and resuspended in 200 ml of 20 mM Tris-HCl 0.5 M NaCl (pH 7.8). After homogenization 5 times in an APV1000 High Pressure Homogenizer (Denmark) at 750 bar on ice, the sample was centrifuged at 12,500 × g for 30 min and filtered through a 0.45- μm-pore-size filter (Sartorius). The recombinant HugZ was purified using the AKTÄ Explorer100 system with a Chelating Fastflow XK1620 column (CV = 18 ml) (GE) in accordance with the manufacturer's standard protocol. Protein purity was determined by SDS-PAGE. Also, Peptide Mass Fingerprint (PMF) analysis was used to identify the HugZ protein (Beijing Genomics Institute). The purified HugZ protein was concentrated and dialyzed three times (Vivaspin 20 centrifugal concentrators, 10 kDa molecular weight cut off, Sartorius) against 20 mM Tris-HCl (pH 7.8) at 4°C and quantified by the Lowry Method (600 μg/ml). The purified protein was used to prepare anti-HugZ antiserum in rabbits in accordance with standard protocols.

Immunoelectron microscopy (IEM)

IEM was performed as described by Michie et al. [34]. Wild type H. pylori 26695 cells were grown in BBF at 37°C overnight, fixed with 10% glutaraldehyde and washed before dehydration at 4°C in 80% ethanol. The cells were frozen in liquid nitrogen for use. For immunolabeling, frozen ultrathin sections were collected on Formvar-coated gold slot grids. Sections were treated with blocking buffer then incubated for 4 h at room temperature with affinity-purified anti-HugZ rabbit antiserum diluted 1:2000 in BB or with BB alone (as a negative control). The grids were washed six times with wash buffer (PBS 0.05% Tween 20), blocked with 5% normal goat serum and incubated in goat anti-rabbit 15-nm gold diluted 1:100 in BB plus 5% goat serum. The grids were washed twice with wash buffer, twice with PBS and twice with water before staining in saturated aqueous uranyl acetate for 20 min. Sections were viewed under a Philips Tecnai 10 transmission electron microscope.

Binding of HugZ to hemin

Two independent assays, which involved hemin-agarose beads and spectrophotometry, were utilized to test the binding activity of HugZ. The hemin agarose-based assay was performed as described by Lee [35]. In brief, 100 μl of hemin-agarose (Sigma-Aldrich) was washed thrice in 10 ml 0.5 M NaCl-20 mM Tris-HCl (pH 7.8), then incubated with purified HugZ (20 μg) with or without 10 nmol hemin for 30 min. After the removal of contaminants, the bound protein was analyzed by 15% SDS-PAGE. The absorption spectroscopy assay was carried out as described by Wilks et al. [21]. One milliliter of 20 μM HugZ (in 20 mM Tris-HCl (pH 7.8)) was applied at 25°C. Hemin (2.5 mM in 20 mM NaOH) was titrated against the HugZ in 2.5 μM increments and the absorbance spectrum between 300 and 800 nm was recorded on a TU-1901 spectrophotometer (Pgeneral, China). The absorption at 411 nm was plotted against the heme concentration.

Determination of hugZ heme oxygenase activity

Heme-HugZ complex was prepared at a hemin:protein ratio of 2:1 and excess heme was removed by filtration through a Sephadex G-25 column. Degradation of HugZ-bound hemin to biliverdin was mediated by two electron-donor systems (ascorbic acid and NADPH-CPR). Ascorbic acid was added to a final concentration of 20 mM. In the NADPH-CPR system, heme-HugZ protein (20 μM) was added to 100 μg of recombinant human NADPH-cytochrome P450 reductase (CPR). The reaction was initiated by adding NADPH to 100 μM and spectra were recorded from 350 nm to 800 nm every 2 min for 1 h. In order to avoid the involvement of non-enzymatic H2O2-mediated conversion of heme to biliverdin, 2 μM catalase (bovine liver, Sigma-Aldrich) was added to the reaction systems [13]. Finally, two heme-HugZ reaction products, biliverdin and carbon monoxide (CO), were determined. First, HPLC was used to detect biliverdin [21]. Second, to determine CO, recombinant human NADPH-CPR (100 μg) and NADPH (100 μM) were placed in both the reference and reaction cuvettes in a final volume of 3 ml and blanked immediately. Then 150 μl of myoglobin (125 μM) (Sigma-Aldrich) was added to the reaction cuvette and the same volume of buffer to the reference cuvette. Spectra were recorded every 2 min between 400 and 700 nm for up to 1 h [13].

Transcriptional analysis of hugZ by real-time RT-PCR

H. pylori RNA was isolated using TRIzol reagent (Gibco/BRL). The RNA concentration was quantified by the OD260, and RNA integrity was verified by visualization on a 2% agarose gel. Real-time quantitative PCR was performed as described by Feng et al. with a minor modification [36]. Briefly, hugZ-specific primers (hugZ1 and hugZ2) (Table (Table1)1) and SYBR Green PCR master mix (ABI) were used. Real-time PCR was performed using a Rotor-Gene 6000 real-time PCR system (Corbett Life Science, Australia). Known concentrations of H. pylori 26695 genomic DNA were used to construct a gene-specific standard curve so that the concentration of template in each reaction could be determined. The gene encoding DNA gyrase subunit B, GyrB (HP0501) [37], was used to normalize all reactions. Melting curve analysis confirmed that all PCRs amplified a single product.

Authors' contributions

QZ, GG and XM conceived and designed the experiments. YG, GG, WZ, JX, TL, BX and XL performed the experiments. YG, YF, GG and XM analyzed the data. GG, WT and YF contributed reagents/materials/analysis tools. YG, YF and GG wrote the paper.

Acknowledgements

We thank Dr. Hong Zhou for the gift of recombinant human p450 CPR, Dr. Yonghong Zhu for detecting the biliverdin by HPLC and Drs. JunYang & PingYang for performing the IEM. This work was supported by the National Natural Science Foundation of China (30400019).

References

  • Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Jr, Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992;116:705–708. [PubMed]
  • Wotherspoon AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull. 1998;54:79–85. [PubMed]
  • Gottke MU, Fallone CA, Barkun AN, Vogt K, Loo V, Trautmann M, Tong JZ, Nguyen TN, Fainsilber T, Hahn HH, et al. Genetic variability determinants of Helicobacter pylori: influence of clinical background and geographic origin of isolates. J Infect Dis. 2000;181:1674–1681. doi: 10.1086/315425. [PubMed] [Cross Ref]
  • Akopyants NS, Eaton KA, Berg DE. Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets. Infect Immun. 1995;63:116–121. [PMC free article] [PubMed]
  • Salaun L, Ayraud S, Saunders NJ. Phase variation mediated niche adaptation during prolonged experimental murine infection with Helicobacter pylori. Microbiology. 2005;151:917–923. doi: 10.1099/mic.0.27379-0. [PubMed] [Cross Ref]
  • Guo G, Tong WD, Zeng H, Liu KY, Zou QM. [Comparative proteomics analysis of Helicobacter pylori after adaptive colonization in Mongolian gerbils] Wei Sheng Wu Xue Bao. 2007;47:461–464. [PubMed]
  • Koga T, Shimada Y, Sato K, Takahashi K, Kikuchi I, Okazaki Y, Miura T, Katsuta M, Iwata M. Contribution of ferrous iron to maintenance of the gastric colonization of Helicobacter pylori in miniature pigs. Microbiological research. 2002;157:323–330. doi: 10.1078/0944-5013-00169. [PubMed] [Cross Ref]
  • Waidner B, Greiner S, Odenbreit S, Kavermann H, Velayudhan J, Stahler F, Guhl J, Bisse E, van Vliet AH, Andrews SC, et al. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infection and immunity. 2002;70:3923–3929. doi: 10.1128/IAI.70.7.3923-3929.2002. [PMC free article] [PubMed] [Cross Ref]
  • Nakao K, Imoto I, Ikemura N, Shibata T, Takaji S, Taguchi Y, Misaki M, Yamauchi K, Yamazaki N. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. The American journal of gastroenterology. 1997;92:1005–1011. [PubMed]
  • Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS microbiology reviews. 2003;27:215–237. doi: 10.1016/S0168-6445(03)00055-X. [PubMed] [Cross Ref]
  • Payne SM. Iron acquisition in microbial pathogenesis. Trends in microbiology. 1993;1:66–69. doi: 10.1016/0966-842X(93)90036-Q. [PubMed] [Cross Ref]
  • Wandersman C, Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annual review of microbiology. 2004;58:611–647. doi: 10.1146/annurev.micro.58.030603.123811. [PubMed] [Cross Ref]
  • Ridley KA, Rock JD, Li Y, Ketley JM. Heme utilization in Campylobacter jejuni. J Bacteriol. 2006;188:7862–7875. doi: 10.1128/JB.00994-06. [PMC free article] [PubMed] [Cross Ref]
  • Wyckoff EE, Schmitt M, Wilks A, Payne SM. HutZ is required for efficient heme utilization in Vibrio cholerae. Journal of bacteriology. 2004;186:4142–4151. doi: 10.1128/JB.186.13.4142-4151.2004. [PMC free article] [PubMed] [Cross Ref]
  • Perry RD, Shah J, Bearden SW, Thompson JM, Fetherston JD. Yersinia pestis TonB: role in iron, heme, and hemoprotein utilization. Infection and immunity. 2003;71:4159–4162. doi: 10.1128/IAI.71.7.4159-4162.2003. [PMC free article] [PubMed] [Cross Ref]
  • Jarosik GP, Sanders JD, Cope LD, Muller-Eberhard U, Hansen EJ. A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b. Infect Immun. 1994;62:2470–2477. [PMC free article] [PubMed]
  • Wilks A, Burkhard KA. Heme and virulence: how bacterial pathogens regulate, transport and utilize heme. Natural product reports. 2007;24:511–522. doi: 10.1039/b604193k. [PubMed] [Cross Ref]
  • Frankenberg-Dinkel N. Bacterial heme oxygenases. Antioxid Redox Signal. 2004;6:825–834. [PubMed]
  • Worst DJ, Otto BR, de Graaff J. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect Immun. 1995;63:4161–4165. [PMC free article] [PubMed]
  • Worst DJ, Maaskant J, Vandenbroucke-Grauls CM, Kusters JG. Multiple haem-utilization loci in Helicobacter pylori. Microbiology (Reading, England) 1999;145:681–688. [PubMed]
  • Wilks A, Schmitt MP. Expression and characterization of a heme oxygenase (Hmu O) from Corynebacterium diphtheriae. Iron acquisition requires oxidative cleavage of the heme macrocycle. The Journal of biological chemistry. 1998;273:837–841. doi: 10.1074/jbc.273.2.837. [PubMed] [Cross Ref]
  • Ishikawa K, Sato M, Yoshida T. Expression of rat heme oxygenase in Escherichia coli as a catalytically active, full-length form that binds to bacterial membranes. European journal of biochemistry/FEBS. 1991;202:161–165. doi: 10.1111/j.1432-1033.1991.tb16357.x. [PubMed] [Cross Ref]
  • Puri S, O'Brian MR. The hmuQ and hmuD genes from Bradyrhizobium japonicum encode heme-degrading enzymes. Journal of bacteriology. 2006;188:6476–6482. doi: 10.1128/JB.00737-06. [PMC free article] [PubMed] [Cross Ref]
  • Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, Lee A, Falkow S. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun. 2003;71:6510–6525. doi: 10.1128/IAI.71.11.6510-6525.2003. [PMC free article] [PubMed] [Cross Ref]
  • Bereswill S, Greiner S, van Vliet AH, Waidner B, Fassbinder F, Schiltz E, Kusters JG, Kist M. Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. Journal of bacteriology. 2000;182:5948–5953. doi: 10.1128/JB.182.21.5948-5953.2000. [PMC free article] [PubMed] [Cross Ref]
  • Stahler FN, Odenbreit S, Haas R, Wilrich J, van Vliet AH, Kusters JG, Kist M, Bereswill S. The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect Immun. 2006;74:3845–3852. doi: 10.1128/IAI.02025-05. [PMC free article] [PubMed] [Cross Ref]
  • Ratliff M, Zhu W, Deshmukh R, Wilks A, Stojiljkovic I. Homologues of neisserial heme oxygenase in gram-negative bacteria: degradation of heme by the product of the pigA gene of Pseudomonas aeruginosa. J Bacteriol. 2001;183:6394–6403. doi: 10.1128/JB.183.21.6394-6403.2001. [PMC free article] [PubMed] [Cross Ref]
  • Zhu W, Hunt DJ, Richardson AR, Stojiljkovic I. Use of heme compounds as iron sources by pathogenic neisseriae requires the product of the hemO gene. J Bacteriol. 2000;182:439–447. doi: 10.1128/JB.182.2.439-447.2000. [PMC free article] [PubMed] [Cross Ref]
  • Kunkle CA, Schmitt MP. Comparative analysis of hmuO function and expression in Corynebacterium species. J Bacteriol. 2007;189:3650–3654. doi: 10.1128/JB.00056-07. [PMC free article] [PubMed] [Cross Ref]
  • Suits MD, Pal GP, Nakatsu K, Matte A, Cygler M, Jia Z. Identification of an Escherichia coli O157:H7 heme oxygenase with tandem functional repeats. Proc Natl Acad Sci USA. 2005;102:16955–16960. doi: 10.1073/pnas.0504289102. [PMC free article] [PubMed] [Cross Ref]
  • Gancz H, Censini S, Merrell DS. Iron and pH homeostasis intersect at the level of Fur regulation in the gastric pathogen Helicobacter pylori. Infect Immun. 2006;74:602–614. doi: 10.1128/IAI.74.1.602-614.2006. [PMC free article] [PubMed] [Cross Ref]
  • Clayton CLaM, Harry LT. Helicobacter pylori Protocols. Humana Press; 1997.
  • Heuermann D, Haas R. A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation. Mol Gen Genet. 1998;257:519–528. doi: 10.1007/s004380050677. [PubMed] [Cross Ref]
  • Michie KA, Monahan LG, Beech PL, Harry EJ. Trapping of a spiral-like intermediate of the bacterial cytokinetic protein FtsZ. J Bacteriol. 2006;188:1680–1690. doi: 10.1128/JB.188.5.1680-1690.2006. [PMC free article] [PubMed] [Cross Ref]
  • Lee BC. Isolation of an outer membrane hemin-binding protein of Haemophilus influenzae type b. Infect Immun. 1992;60:810–816. [PMC free article] [PubMed]
  • Feng Y, Li M, Zhang H, Zheng B, Han H, Wang C, Yan J, Tang J, Gao GF. Functional definition and global regulation of Zur, a zinc uptake regulator in a Streptococcus suis serotype 2 strain causing streptococcal toxic shock syndrome. J Bacteriol. 2008;190:7567–7578. doi: 10.1128/JB.01532-07. [PMC free article] [PubMed] [Cross Ref]
  • Zeng H, Guo G, Mao XH, De Tong W, Zou QM. Proteomic Insights into Helicobacter pylori Coccoid Forms Under Oxidative Stress. Curr Microbiol. 2008;57:281–286. doi: 10.1007/s00284-008-9190-0. [PubMed] [Cross Ref]

Articles from BMC Microbiology are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...